[Cefepime (maxipime) in the treatment of severe urinary tract infection]

I I Derevianko1

  • 1Research Insitute of Urology, Ministry of Public Health of the Russian Federation, Moscow.

Insights

Cefepime demonstrated high clinical and bacteriological efficacy in treating complicated urinary tract infections (cUTIs). This study compared its effectiveness against other antibiotics, finding it a successful monotherapy option for cUTI patients.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Complicated urinary tract infections (cUTIs) pose a significant clinical challenge.
  • Antimicrobial resistance necessitates evaluation of effective treatment options.

Purpose of the Study:

  • To compare the susceptibility of microflora isolates from cUTI patients to cefepime and other antibiotics.
  • To evaluate the clinical and bacteriological efficacy of cefepime monotherapy in treating cUTIs.

Main Methods:

  • Microflora isolates from cUTI patients were identified.
  • Susceptibility testing was performed for cefepime, other cephalosporins, amikacin, ciprofloxacin, and ofloxacin.
  • Patients received cefepime monotherapy (1-2g daily) for 7-14 days.

Main Results:

  • Cefepime exhibited high clinical efficacy at 93.2%.
  • Bacteriological efficacy of cefepime was 85.4%.
  • Isolates were identified within diagnostic titers ranging from 5 x 10(4) to 5 x 10(8).

Conclusions:

  • Cefepime is an effective etiotropic monotherapy for complicated urinary tract infections.
  • The study supports the use of cefepime in managing cUTIs based on its high efficacy rates.

Related Concept Videos

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs like...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...